Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. Despite its indolent clinical course, therapy refractoriness and disease progression still represent an unmet clinical need. Before the advent of pathway inhibitors, chemoimmunotherapy (CIT) was the commonest option for CLL tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Maher, Nawar, Mouhssine, Samir, Matti, Bassam Francis, Alwan, Alaa Fadhil, Gaidano, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299596/
https://www.ncbi.nlm.nih.gov/pubmed/37373521
http://dx.doi.org/10.3390/ijms241210374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299596/
https://www.ncbi.nlm.nih.gov/pubmed/37373521
http://dx.doi.org/10.3390/ijms241210374

Ejemplares similares